Profit and Loss Results Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Mar'24
Dec'21
Dec'20
No of Months
12
12
12
Operating Income
80.00
0.00
0.00
Less :Inter divisional transfers
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
Net Sales
80.00
0.00
0.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
Operating Expenses
6.00
0.00
0.00
General and Administration Expenses
62.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
Total Expenditure
121.00
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-40.00
0.00
0.00
Other Income
4.00
0.00
0.00
Operating Profit (PBDIT)
-30.00
0.00
0.00
Interest
6.00
0.00
0.00
Profit before Depriciation and Tax
0.00
0.00
0.00
Depreciation
5.00
0.00
0.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
Profit Before Tax
-64.00
0.00
0.00
Provision for Tax
-3.00
0.00
0.00
Profit After Tax
-61.00
0.00
0.00
Extraordinary Items
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
-5.71
-0.18
-0.00
Profit And Loss Analysis Highlights
Compare Profit and Loss Results of YS Biopharma Co. Ltd.
Figures in Million
consolidated - Profit And Loss Results
Change(USD)
Change(%)
No of Months
12
12
Operating Income
80.00
0.00
80.00
0%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
80.00
0.00
80.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
6.00
0.00
6.00
0%
General and Administration Expenses
62.00
15.00
47.00
313.33%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
121.00
27.00
94.00
348.15%
Operating Profit (PBDIT) excl Other Income
-40.00
-27.00
-13.00
-48.15%
Other Income
4.00
8.00
-4.00
-50.00%
Operating Profit (PBDIT)
-30.00
-18.00
-12.00
-66.67%
Interest
6.00
0.00
6.00
0%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
5.00
0.00
5.00
0%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-64.00
-73.00
9.00
12.33%
Provision for Tax
-3.00
0.00
-3.00
0%
Profit After Tax
-61.00
-73.00
12.00
16.44%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-5.7139
-1.5343
-4.18
-272.41%
Profit and Loss - Net Sales
Analysis not available as Data has been published for only 1 period
Profit and Loss - Operating Profit (PBDIT)
Analysis not available as Data has been published for only 1 period
Profit and Loss - Interest
Analysis not available as Data has been published for only 1 period
Profit and Loss - Profit After Tax
Analysis not available as Data has been published for only 1 period
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
